Dysregulated JNK signaling contributes to a variety of diseases involving metabolic disorders, chronic inflammation, autoimmune diseases, neurodegeneration, cancer, infectious diseases, and other diseases such as ischemia/reperfusion injury, hearing loss/deafness, and kidney fibrosis. This evidence concerns the gene MAPK8 and metabolic disease.